Abstract
Purpose :
Intraocular pressure (IOP), arterial blood pressure (PA) and cerebrospinal fluid pressure (CSFp) have been identified as major players in several ocular pathologies, including glaucoma, central vein occlusion and papilledema to name a few. However, IOP, PA and CSFp are not independent from each other. For example, aqueous humor and CSF flows, whose mechanics contribute to establish IOP and CSFp levels, originate from blood flow, which is driven by PA. As a consequence, it is difficult to isolate experimentally IOP, PA and CSFp and to disentangle their effect in pathological conditions. Here we utilize a theoretical approach to address this issue.
Methods :
A mathematical model is developed to simulate fluid flow in the eyes and brain within a simplified description of the whole-body circulation (Fig.1). The model accounts for: (i) the flows of blood and aqueous humor in the eyes; (ii) the flows of blood, cerebrospinal fluid and interstitial fluid in the brain; and (iii) their interactions. The flow is driven by PA, which is given as a variable input, while the venous pressure PV is kept constant. Model parameters have been calibrated on published data. The model is used to simulate changes in IOP, CSFp, flow and pressure distributions across the whole system induced by changes in PA. Results are compared those reported in clinical studies.
Results :
Model predicted relationships between IOP, PA and CSFp are within the same range as those reported in clinical studies (Fig2a,b,c). In addition, choroidal venous pressure in the vortex veins computed by the model from flow and pressure distribution within the body results to be approximately equal to IOP over a wide range of values (Fig2c), confirming the findings by A. Bill (The uveal venous pressure. Archives of Ophthalmology, 69(6):780-782. (1963)).
Conclusions :
Simulation results validate the predictive capability of the model, which provides a powerful virtual laboratory where the relationships between IOP, PA, CSFp could be assessed based on patient's conditions. Thus, our model may have an important clinical role as medicine is moving in the direction of tailoring treatments for specific patients.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.